Skip to content

Willis Towers Watson Public stock

WTWNASDAQ

Willis Towers Watson Public Limited Company, Financial ServicesISIN IE00BDB6Q211

$328.78▼ $5.40 (−1.6%)Closing price of 12 Nov 2026

75Score 75 out of 100, Strong

Turn on early warning

Price and trend

85 / 100

Price history

+2.7% in one year

The chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Above the 200-day line: the price is 11% above it.

Trend change

Since August 2026 the 50-day line has been above the 200-day line; the trend has turned up.

Momentum

Normal: the price is neither overheated nor sold off (RSI 54).

Distance to the high

The price is 6.3% below its 52-week high. Largest decline in 20 years: 59% (May 2007 to March 2009).

Chart figures for advanced users
SMA 50$313.04
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$297.08
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)54
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$242.12
The lowest closing price of the last twelve months.
Resistance$350.75
The highest closing price of the last twelve months.
Market cap
$30.82B
Div. yield
1.14%
12 months
20.1
14.9
on earnings for the next twelve months ($22.49 per share)
Fair value
$489.21

Snapshot

Computed from the data by fixed rules, no AI

  • Willis Towers Watson Public Limited Company belongs to the Insurance (Brokers) industry (United Kingdom) and, with a market value of $30.32B, is number 4 of 14 companies in its industry on MEQIRI.
  • For fiscal 2026, analysts expect on average revenue of $10.45B (up 7.6%) and adjusted earnings per share of $19.84 (up 15.5%).
  • MEQIRI Score 75 out of 100 (Strong): rank 243 of 976 in Financial Services, median 68.
Show more
  • The P/E is 19.8 (Insurance (Brokers) median 24.5, own median of recent years 27.2).
  • Our model puts fair value at $489.21, with the price 32% below it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Share buybacksShare count down 25% since 2020.Capital allocation 82
  • Earnings per share growingUp 22% a year since 2022.Growth 60
  • Below fair valuePrice 32% below the fair value of $489.21.Valuation 77

Weaknesses

None of our weakness checks flags anything. Crash risk is measured separately.

75/ 100
MEQIRI Score
Strong

Its standout strengths are fundamentals and technical analysis.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

Fundamentals are strong, with stable profits and strong cash generation.

Profit consistency90% of years
Cash conversion (free cash flow to earnings, 12 months)111%
ROIC (12 months)14.7%
Positive free cash flow100% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk low

How well MEQIRI warns

One of the 30% with the lowest crash risk among stocks ranked 101 to 1,000.

From 2016 to 2025, 9 in 100 such stocks fell 30% or more within a year, against a group average of 15 in 100.

What lowers it

  • solid fundamentals
  • price near its 52-week high

Valuation

Valuation signal

Significantly undervalued
Price
$334.18
Fair value
$489.21
Gap to fair value
−32%

Closing price of 11 Nov 2026, used by the daily score.

In our model the price counts as cheap below $376.32 and expensive above $698.88 (uncertainty medium, based on the price swings of the past year).

The two parts of the fair value come to $570.29 (cash-flow model) and $408.14 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $438.56, at 7.8% it would be $565.44.

Valuation metrics

1.37
13.2
Fair value (model)
$489.21
Earnings part $408.14 (earnings per share $16.64 × 24.5)

Half from the cash-flow model, half from earnings times the industry P/E (24.5).

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

20 years

In the twelve months to 30 Sep 2026, revenue rose 4.8% on the twelve months before. Revenue has grown solidly since 2006, at about 8% per year.

Margins

20 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross 42%, operating 23%, net 17%.

Debt & balance sheet

latest quarter
0.91
8.7x
1.1
Cash & equivalents
$1.95B

The balance sheet is solid, with moderate debt and comfortable interest coverage.

Earnings

Next earnings
2 Feb 2027in 82 days
Last reported
29 Oct 2026EPS reported $3.63 (expected $3.59)in line with expectations

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 202612 analysts
Earnings per share
$19.84+0.2%
Revenue
$10.45B−0.1%
Fiscal 202712 analysts
Earnings per share
$22.910.0%
Revenue
$11.01B0.0%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook lowered

Share price after the results: +0.9%

WTW lowered several 2026 segment outlooks: Career now expected at low single-digit growth instead of low to mid-single-digit, BD&O revenue now roughly flat instead of low single-digit growth, overall HWC now low to mid-single-digit instead of mid-single-digit growth, and ICT now low single-digit …

Supporting passage from the call, verbatim
“As a result, we now expect BD&O revenue to be roughly flat for 2026, compared with our prior expectation of low single-digit growth. At the Health, Wealth & Career level, we now expect low to mid-single digit organic growth for the full-year.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 29 Oct 2026 (fiscal Q3 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases in the last 6 months. One insider sold, $250,172 in total.

Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.

  • Faber AlexisSale

    10 Aug 2026, Chief Operating Officer

    Shares
    730
    Price
    $342.70
    Value
    $250,172

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Willis Towers Watson Public

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

976 rated companies in Financial Services

Rank 243 of 976
243/ 976
This company
75
Sector median
68

Categories against the sector median

ProfitabilityMedian of 976 companies69 (median 57)12 above the median
GrowthMedian of 976 companies60 (median 67)7 below the median
FundamentalsMedian of 976 companies87 (median 80)7 above the median
ValuationMedian of 929 companies with a value77 (median 73)4 above the median
StabilityMedian of 976 companies67 (median 78)11 below the median
Capital allocationMedian of 976 companies82 (median 56)26 above the median
Technical analysisMedian of 976 companies85 (median 70)15 above the median
MomentumMedian of 976 companies78 (median 70)8 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Insurance (Brokers)

The next larger and next smaller companies by market value

All 14 Insurance (Brokers) stocks

ETFs that hold Willis Towers Watson Public

Held by 59 ETFs on Xetra. Shown per index: the ETF with the largest weight.

ETFWeightCostFund size
Amundi Global Gender Equality UCITS ETF AccVOOM0.71%0.20%€55.72M
iShares Ageing Population UCITS ETF2B770.61%0.40%€807M
iShares MSCI USA Mid-Cap Equal Weight UCITS ETFQDVC0.43%0.20%€268.74M
Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Strong, published since 7 Nov 2026 (in the score history since 18 Oct 2026)
  • Valuation signal Undervalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy